Notably, in obese individuals without diabetes, the most responsive diagnostic algorithms—METS-IR, TyG, and HSI—do not require insulin measurement, highlighting the need for a more individualized and multi-modal approach in monitoring treatment response and disease progression in this specific population. The gene discussed is INS; the disease is diabetes mellitus.